Respiratory (Pharm) Flashcards
Allergic rhinitis
-Induced after allergen exposure
-Symptomatic disorder of the nose
-Sneezing, nasal pruritus, airflow obstruction and nasal discharge, +/- conjunctivitis, Bilateral (NOT unilateral symptoms)
-Different classification for severity and duration
-Always check for asthma especially in patients with severe and or persistent rhinitis
Allergic rhinitis pathophysiology
-Exposure of allergen, dendritic cells try to clean up
-Antigen presentation and release of mast cells causing allergic reaction, re-exposure releases histamine
-IgE
-Basophil
-Th2 inflammation
What is NOT allergic rhinitis?
-Unilateral symptoms
-Nasal obstruction without other symptoms
-Mucopurulent rhinorrhea
-Post nasal drip with thick mucus and no anterior rhinorrhea
-Pain
-Recurrent epistaxis
Pharmacological treatment of allergic rhinitis
-Oral antihistamine (1st gen drowsy cross BBB, 2nd generation non drowsy but needs to be taken before exposure due to it not blocking histamine and does not cross BBB)
-Nasal antihistamine (takes few days for effect)
-Intranasal corticosteroids
-Oral decongestants ( work on alpha-adrenergic receptors to cause vasoconstriction, careful for patients with HTN, DM and narrow angle glaucoma, hyperthyroidism, BPH)
-Nasal decongestants (only use 3-7 days to avoid rebound congestion)
-Anti-cholinergic (for runny nose) such as ipratropium
-LTRA (Leukoterine receptor antagonist)
-Normal saline flushes, intraocular
Asthma goals of therapy
-Control of symptoms
-Maintain normal activity
-Maintain pulmonary function as close to normal
-Prevent asthma exacerbations
-Avoid S/E of medications
-PEF>90%
Assessment of asthma
- Asthma control, assess over 4 weeks, hospital admissions
- Treatment issues: check inhaler technique and adherence, side effects, written asthma action plan
- Comorbidities: think about GERD, obesity, OSA, rhinositusitis
-Assessment: day and night symptoms, physical activity, exacerbations, absence from work or school, need for reliever, FEV or PEF, sputum eosinophils
Medications for asthma
-SABA (short acting beta 2 agonist, increase CAMP and causes bronchodilation)
-ICS (shown to decrease exacerbations and increase lung function, may take 8 weeks for full effect)
-ICS/LABA combos (LABA is NEVER used on its own without corticosteroid)
-LTRA (inhibition of leukotriene receptors these are correlated with airway edema and smooth muscle contraction with an inflammatory process)
-LAMA (long acting muscarinic antagonist)
-Oral steroids
-Anti-IgE
-IL-antagonists
Long term side effects of ICS (controller) use
-Oral thrush and hoarseness
-Adrenal insufficiency
-Hyperglycemia
-Osteoporosis
-Pneumonia
-Cataracts
-Dermal thinking
Side effects of SABA (reliever)
-Tremor
-QT prolongation
-Increase HR
-Increase insulin secretion
-Hypokalemia
Side effect of LABA (slower to associate than SABA)
-Tremor
-QT prolongation
-Increase HR
-Increase insulin secretion
-Hypokalemia
Side effects of LAMA (controller)
-Dry mouth, cough, constipation, urinary retention,headache
COPD
-FEV1/FVC< 0.7
-airflow limitation
-progressive
-abnormal inflammatory response of the lung to noxious particles or gases
-severity of COPD based on FEV
-assess with modified MRC dyspnea scale or CAT tool
-common comorbidities with COPD: DM, CV problems, PVD, anxiety depression, chronic anemia, osteoporosis
COPD pharmacological treatment
-A bronchodilator (increase FEV by altering smooth muscle tone, improves lung emptying, reduces hyperinflation)
-LABA+LAMA
-LABA+LAMA
-LABA+LAMA+ICS (if blood eos>300)-improves long function and exacerbations
-oral steroids
-macrolide antibiotics (for anti-inflammatory and antibacterial to reduce chronic airway inflammation and mucus production)